Skip to main content
. 2017 Oct 26;10(5):280–287. doi: 10.14740/gr908w

Table 2. Endoscopic Findings and Management of VCE and Non-VCE Encounters.

Capsule (n = 15) No capsule (n = 25) P value
Findings
  AVM (%) 46.7 (21.3 - 73.4) 32.0 (14.9 - 53.5) 0.502
  Ulcer or erosion (%) 33.3 (11.8 - 61.6) 20.0 (6.8 - 40.7) 0.457
  Gastritis (%) 13.3 (1.7 - 40.5) 12.0 (2.5 - 31.2) 1.000
  Polyp (%) 40.0 (16.3 - 67.7) 8.0 (0.9 - 26.0) 0.036
  GAVE (%) 13.3 (1.7 - 40.5) 4.0 (0.1 - 20.4) 0.545
Endoscopic intervention
  APC (%) 40.0 (16.3 - 67.7) 24.0 (9.4 - 45.1) 0.311
  Clip (%) 13.3 (1.7 - 40.5) 12.0 (2.5 - 31.2) 1.000
  Injection (%) 0 (0 - 21.8) 0 (0 - 13.7) 1.000
  Snare (%) 6.7 (0.1 - 31.9) 0 (0 - 13.7) 0.375
Management
  IR intervention (%) 6.7 (0.2 - 31.9) 0 (0 - 13.7) 0.375
  Tagged RBC scan (%) 0 (0 - 21.8) 8.0 (0.9 - 26.0) 0.519
  Start octreotide or thalidomide (%) 46.7 (21.3 - 73.4) 52.0 (31.3- 72.2) 1.000
  Double balloon enteroscopy (%) 20.0 (4.3 - 48.1) 12.0 (2.5 - 31.2) 0.654
  Push enteroscopy (%) 6.7 (0.2 - 31.9) 12.0 (2.5 - 31.2) 1.000
  Any enteroscopy (%) 26.7 (7.8 - 55.1) 20.0 (6.8 - 40.7) 0.705

AVM: arteriovenous malformation; GAVE: gastric antral vascular ectasia; APC: argon plasma coagulation; IR: interventional radiology; RBC: red blood cell.